Identification of plasma protein profiles associated with risk groups of prostate cancer patients.

Summary, in English

Early detection of prostate cancer (PC) using prostate-specific antigen (PSA) in blood reduces PC-death among unscreened men. However, due to modest specificity of PSA at commonly used cut-offs, there are urgent needs for additional biomarkers contributing enhanced risk classification among men with modestly elevated PSA.

• Author: Malin Nordström; Christer Wingren; Carsten Rose; Anders Bjartell; Charlotte Becker; Hans Lilja; Carl A K Borrebaeck
• Department/s: Clinical Chemistry, Malmö; Division of Translational Cancer Research; Breastcancer-genetics; BioCARE: Biomarkers in Cancer Medicine improving Health Care, Education and Innovation; Urological cancer, Malmö; EpiHealth: Epidemiology for Health
• Publishing year: 2014
• Language: English
• Pages: 951-962
• Publication/Series: Proteomics Clinical Applications
• Volume: 8
• Issue: 11-12
• Full text: - 5 kB; Download statistics
• Links: http://www.ncbi.nlm.nih.gov/pubmed/25196118?dopt=Abstract; http://dx.doi.org/10.1002/prca.201300059
• Document type: Journal article
• Publisher: John Wiley & Sons Inc.
• Topic: Cell and Molecular Biology
• Status: Published
• Research group: Clinical Chemistry, Malmö; Urological cancer, Malmö
• ISBN/ISSN/Other: ISSN: 1862-8354